SIVORI, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 15.251
AS - Asia 1.563
NA - Nord America 727
SA - Sud America 121
AF - Africa 20
OC - Oceania 2
Totale 17.684
Nazione #
IT - Italia 14.964
US - Stati Uniti d'America 697
SG - Singapore 680
CN - Cina 425
VN - Vietnam 304
FR - Francia 121
BR - Brasile 84
FI - Finlandia 54
HK - Hong Kong 53
DE - Germania 25
GB - Regno Unito 22
JP - Giappone 20
MX - Messico 18
IQ - Iraq 16
AR - Argentina 15
NL - Olanda 13
BD - Bangladesh 10
CA - Canada 9
CH - Svizzera 9
ID - Indonesia 9
ES - Italia 7
IN - India 7
PH - Filippine 7
EC - Ecuador 6
PL - Polonia 6
RU - Federazione Russa 6
UA - Ucraina 6
TH - Thailandia 5
TN - Tunisia 5
IE - Irlanda 4
VE - Venezuela 4
ZA - Sudafrica 4
AL - Albania 3
CO - Colombia 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
TR - Turchia 3
AU - Australia 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 17.684
Città #
Genova 8.950
Genoa 3.600
Rapallo 1.172
Vado Ligure 1.074
Singapore 319
San Jose 278
Ashburn 135
Lauterbourg 111
Ho Chi Minh City 98
Hanoi 70
Beijing 64
Helsinki 53
Hong Kong 51
Council Bluffs 48
Bordighera 46
Milan 42
Santa Clara 31
Frankfurt am Main 24
Los Angeles 21
New York 17
Tokyo 17
Mexico City 15
Haiphong 14
Valenza 13
Da Nang 12
Rome 10
Des Moines 9
Tianjin 9
Shanghai 8
São Paulo 8
Zurich 8
Amsterdam 7
Baghdad 6
Cardiff 6
Bologna 5
Chicago 5
London 5
Warsaw 5
Biên Hòa 4
City of London 4
Dublin 4
Jakarta 4
Naples 4
Orem 4
Quảng Ngãi 4
Atlanta 3
Brasília 3
Brooklyn 3
Buenos Aires 3
Chieti 3
Dallas 3
Marseille 3
Montreal 3
Ninh Bình 3
Rovereto 3
Albuzzano 2
Ankara 2
Bangkok 2
Barcelona 2
Basingstoke 2
Buffalo 2
Cairo 2
Can Tho 2
Caracas 2
Chennai 2
Esmeraldas 2
Formosa 2
Guangzhou 2
Guayaquil 2
Ha Long 2
Hải Dương 2
Itanhaém 2
Kyiv 2
Long Xuyen 2
Medellín 2
Minneapolis 2
Mumbai 2
Nairobi 2
Nha Trang 2
North Bergen 2
Oslo 2
Paris 2
Pisa 2
Porto Alegre 2
Quezon City 2
Rondonópolis 2
San José 2
Santo André 2
Seeb 2
Shenzhen 2
Suzhou 2
Sydney 2
Thái Bình 2
Thái Nguyên 2
Venice 2
Aktobe 1
Albuquerque 1
Amman 1
Ananindeua 1
Arequipa 1
Totale 16.509
Nome #
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 242
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 231
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 226
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 213
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 211
2B4 functions as a co-receptor in human NK cell activation 208
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 200
Bridging innate NK cell Functions with Adaptive Immunity. 199
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 198
Features of Memory-Like and PD-1+ Human NK Cell Subsets 197
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 196
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 193
NK/DC crosstalk in anti-viral response. 193
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 192
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 185
Function and specificity of human natural killer cell receptors. 184
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 181
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 181
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 178
Markers and function of human NK cells in normal and pathological conditions 177
NK cells and their receptors during viral infections. 175
CD56 is a pathogen recognition receptor on human natural killer cells 174
Harnessing NK Cells for Cancer Treatment 171
Human NK receptors: from the molecules to the therapy of high risk leukemias. 169
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 168
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 167
Stimulatory receptors in NK and T cells. 165
Human NK cell response to pathogens 164
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 162
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: novel insights on KIR polymorphism, ligand recognition, expression and function 162
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 161
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 159
Natural killer lymphocytes: "null cells" no more. 154
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 154
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 151
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products 150
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 149
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 149
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 148
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 148
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients 146
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 145
Pathogen-induced private conversations between natural killer and dendritic cells 144
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. 144
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 143
NK Cell-Based Immunotherapy in Colorectal Cancer 142
Natural killer cell-triggering receptors in patients with acute leukaemia. 142
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 141
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 141
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 140
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 139
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 139
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 138
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 138
TLR/NCR/KIR: Which One to Use and When? 138
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 138
Identification of a new surface molecule involved in the mechanism of cell to cell adhesion between human NK and tumor target cells. 137
NK Cell-Based Immunotherapy for Hematological Malignancies 136
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 136
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. 134
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 133
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. 131
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content 130
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. 129
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 129
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 129
Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering. 128
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 127
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. 127
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 127
ANALYSIS OF THE INTERACTION OF MATURING NK CELLS WITHREPLICATING VIRUSES: STRONG UPREGULATION OF NCREXPRESSION AND OF CYTOTOXICITY BY HSV-1, NOT BY HIV-1 126
NK cells: innate immunity against hematological malignancies? 126
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4(+) T Lymphocytes of Sézary Syndrome Patients. 125
NK Receptors: Tools for a Polyvalent Cell Family 125
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 125
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 124
Human natural killer cell receptors and co-receptors. 123
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 123
Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. 122
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 122
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. 121
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 120
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 119
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. 118
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. 118
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 118
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 117
General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. 116
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 116
Elementi di istologia e cenni di embriologia 116
Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. 114
In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-like Receptor 4 and Induces Activation of Monocytes. 114
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 112
Biologia-citologia medica 112
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications 112
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 111
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 110
ISTOLOGIA di Monesi 7 109
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 109
Anti-CD94-induced expansion of highly functional adaptive NKG2C+NKG2A−CD57+selfKIR+ NK cells from CMV-seropositive healthy donors 109
Totale 14.808
Categoria #
all - tutte 54.408
article - articoli 47.406
book - libri 1.022
conference - conferenze 4.933
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.047
Totale 108.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 135 85 91
2021/20221.471 57 107 130 149 53 91 80 331 72 152 67 182
2022/20231.445 156 109 17 148 224 247 2 122 257 10 129 24
2023/2024773 48 94 17 93 71 76 36 78 56 46 47 111
2024/20252.547 62 180 136 150 357 253 235 373 93 131 251 326
2025/20263.994 524 121 284 304 598 412 740 246 354 411 0 0
Totale 17.963